Skip to main content
Clinical Trials/IRCT20140818018842N14
IRCT20140818018842N14
Completed
Phase 3

The randomized single-blinded clinical trial comparing growth hormone effect versus placebo on Improving the outcome of pregnancy in infertile patients.

Deputy of Research and Technology, Tehran University of Medical Sciences.0 sites105 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
poor ovarian response.
Sponsor
Deputy of Research and Technology, Tehran University of Medical Sciences.
Enrollment
105
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Deputy of Research and Technology, Tehran University of Medical Sciences.

Eligibility Criteria

Inclusion Criteria

  • Sign the informed consent form
  • Patients with poor ovarian response based on criteria provided by the Union embryology and infertility Europe 2011\.
  • Strong history of poor ovarian response (Having a maximum of three ovum after inducing ovulation protocols)
  • Low score ovarian reserve (AFC less than 7, AMH less than 0\.5\-1\.1 ng/ml)

Exclusion Criteria

  • Women with high levels of FSH (more than 20 IU/L)
  • Women with a history of infertility due to known non poor ovarian resonce
  • Women with diabetes (type I or II)

Outcomes

Primary Outcomes

Not specified

Similar Trials